Virus News and Research

Latest Virus News and Research

Bacteria-free method for making SARS-CoV-2 infectious clones

Using a circular polymerase chain reaction, researchers have developed a method for making severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recombinant virus, with the ability to introduce mutations. The research by Japanese scientists is published on the preprint server bioRxiv* in September 2020.

27 Sep 2020

Human recombinant soluble ACE2 successfully used in a patient with severe COVID-19

A multinational research group recently published a paper in the journal Lancet Respiratory Medicine which describes the first patient with a severe form of coronavirus disease (COVID-19) that was successfully treated with human recombinant soluble ACE2.

27 Sep 2020

Complex SARS-CoV-2 serology means universal immunological assay is not feasible

As we improve our understanding of immune responses and correlates of protection against the severe acute respiratory syndrome coronavirus (SARS-CoV-2), two UK researchers emphasize that we will probably utilize different assays to tackle specific questions. Their commentary is published in the prestigious journal Lancet Infectious Diseases.

27 Sep 2020

Criticisms of COVID-19 models appear to undermine public trust in science

Criticisms of COVID-19 models by Democratic elites in May 2020 appeared to undermine public support for the models' use - and trust in science more broadly - according to a series of survey experiments conducted with the participation of more than 6,000 Americans.

26 Sep 2020

Masks and face coverings are effective in reducing the spread of airborne particles

Laboratory tests of surgical and N95 masks by researchers at the University of California, Davis, show that they do cut down the amount of aerosolized particles emitted during breathing, talking and coughing.

26 Sep 2020

Mathematical model helps to better understand the dynamics of interactions between viruses

The framework, published in Frontiers in Microbiology, was applied on transmission data of the influenza virus, and offers to be a new tool for anticipating the consequences of microbial diversity and optimizing disease control measures.

26 Sep 2020

Combination of heat and high relative humidity can disinfect N95 mask materials

As the COVID-19 pandemic swept around the world early this year, shortages of protective equipment such as N95 masks left healthcare workers little choice but to reuse the masks they had - increasing the risk of infection for both them and their patients.

26 Sep 2020

Addressing the impact of COVID-19 pandemic on global mental health

In a special session addressing global mental health before, during and after the COVID-19 pandemic held at the ESCMID Conference on Coronavirus Disease (ECCVID) Professor Vikram Patel H(arvard Medical School, USA) will present a new review of the impact of the COVID-19 pandemic on global mental health.

26 Sep 2020

SARS-CoV-2 emergence linked with decrease in circulation of common respiratory viruses

Analysis of samples taken to test for respiratory viruses over the past five years suggests that the emergence of SARS-CoV-2 was associated with a large drop in circulation of other common respiratory viruses during the first wave.

26 Sep 2020

Researchers develop a stable nano-carrier for medications

Medications often have unwanted side-effects. One reason is that they reach not only the unhealthy cells for which they are intended, but also reach and have an impact on healthy cells.

25 Sep 2020

New trial tests combination antibody treatment for preventing COVID-19 illness

A combination antibody treatment for preventing COVID-19 illness in individuals who have had sustained exposure to someone with the virus is being studied by researchers at The University of Texas Health Science Center at Houston.

25 Sep 2020

University of Minnesota receives funding to initiate research on diabetes drug as a COVID-19 treatment

University of Minnesota Medical School researchers received funding from the Parsemus Foundation to initiate research on the widely-used diabetes medication, metformin, available globally as an inexpensive generic drug for prevention and treatment for COVID-19.

25 Sep 2020

3D-printed alternative performs as well as the standard nasal swabs for COVID-19 testing

As COVID-19 quickly spread worldwide this spring, shortages of supplies, including the nasopharyngeal (nasal) swabs used to collect viral samples, limited diagnostic testing.

25 Sep 2020

Ultrapotent antibody mix locks infection machinery, inhibits SARS-CoV-2 attachment to cells

A mix of ultrapotent antibodies from recovered COVID-19 patients has been shown to recognize and lock down the infection machinery of the pandemic coronavirus and keep it from entering cells. Each of the antibody types performs these overlapping tasks slightly differently.

25 Sep 2020

Study identifies potential drug target for dangerous E. coli infections

Escherichia coli, known as E. coli, are bacteria which many people associate with causing mild food poisoning, but some types of E. coli can be fatal.

25 Sep 2020

New diagnostic tool may allow on-the-spot detection of coronavirus infection

Scientists at the University of Warwick have demonstrated that a potential diagnostic tool for detecting Covid-19 using sugars will work with a virus rather than just its proteins, a significant step in making it a viable test in future.

25 Sep 2020

Patients with severe COVID-19 have antibodies blocking body's important defense mechanisms

Persons with critical corona-disease may have antibodies blocking the body´s most important defence mechanisms.

25 Sep 2020

D614G mutation now the dominant variant in the global COVID-19 pandemic

Now, a new study published on the preprint server medRxiv in September 2020 shows that a significant variant characterized by the D614G mutation has higher infectivity, which may account for its rapid rise to the dominant position in all regions where it has emerged.

25 Sep 2020

About 10% patients with severe disease create auto-antibodies that attack the immune system

People infected by the novel coronavirus can have symptoms that range from mild to deadly. Now, two new analyses suggest that some life-threatening cases can be traced to weak spots in patients' immune systems.

25 Sep 2020

Faulty genes and an autoimmune condition linked to severe COVID-19 in young, healthy people

More than 10 percent of young and healthy people who develop severe COVID-19 have misguided antibodies that attack not the virus, but the immune system itself, new research shows. Another 3.5 percent, at least, carry a specific kind of genetic mutation.

25 Sep 2020

Virus News and Research

Latest Virus News and Research

Bacteria-free method for making SARS-CoV-2 infectious clones

Human recombinant soluble ACE2 successfully used in a patient with severe COVID-19

Complex SARS-CoV-2 serology means universal immunological assay is not feasible

Criticisms of COVID-19 models appear to undermine public trust in science

Masks and face coverings are effective in reducing the spread of airborne particles

Mathematical model helps to better understand the dynamics of interactions between viruses

Combination of heat and high relative humidity can disinfect N95 mask materials

Addressing the impact of COVID-19 pandemic on global mental health

SARS-CoV-2 emergence linked with decrease in circulation of common respiratory viruses

Researchers develop a stable nano-carrier for medications

New trial tests combination antibody treatment for preventing COVID-19 illness

University of Minnesota receives funding to initiate research on diabetes drug as a COVID-19 treatment

3D-printed alternative performs as well as the standard nasal swabs for COVID-19 testing

Ultrapotent antibody mix locks infection machinery, inhibits SARS-CoV-2 attachment to cells

Study identifies potential drug target for dangerous E. coli infections

New diagnostic tool may allow on-the-spot detection of coronavirus infection

Patients with severe COVID-19 have antibodies blocking body's important defense mechanisms

D614G mutation now the dominant variant in the global COVID-19 pandemic

About 10% patients with severe disease create auto-antibodies that attack the immune system

Faulty genes and an autoimmune condition linked to severe COVID-19 in young, healthy people

A new way of characterising biomolecules eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in